Gastric Cancer Drug Development Shifting from Small Molecules to Monoclonal Antibodies

Worldwide: Our Business partners GBI Research’s new report “Frontier Pharma: Gastric Cancer - Early Stage Pipeline Innovation Shows Shift towards Targeted mAbs” analysis of the gastric cancer treatment pipeline, stratified by stage of development, molecule type and molecular target. It